Type I interferons promote cross-priming: more functions for old cytokines - PubMed (original) (raw)

Comment

Type I interferons promote cross-priming: more functions for old cytokines

Anne-Sophie Beignon et al. Nat Immunol. 2003 Oct.

No abstract available

PubMed Disclaimer

Comment on

• Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon.
  Le Bon A, Etchart N, Rossmann C, Ashton M, Hou S, Gewert D, Borrow P, Tough DF. Le Bon A, et al. Nat Immunol. 2003 Oct;4(10):1009-15. doi: 10.1038/ni978. Epub 2003 Sep 21. Nat Immunol. 2003. PMID: 14502286

Similar articles

• Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon.
  Le Bon A, Etchart N, Rossmann C, Ashton M, Hou S, Gewert D, Borrow P, Tough DF. Le Bon A, et al. Nat Immunol. 2003 Oct;4(10):1009-15. doi: 10.1038/ni978. Epub 2003 Sep 21. Nat Immunol. 2003. PMID: 14502286
• Priming of CD8+ T cell responses by pathogens typically depends on CD70-mediated interactions with dendritic cells.
  Schildknecht A, Miescher I, Yagita H, van den Broek M. Schildknecht A, et al. Eur J Immunol. 2007 Mar;37(3):716-28. doi: 10.1002/eji.200636824. Eur J Immunol. 2007. PMID: 17295392
• Rapid activation of spleen dendritic cell subsets following lymphocytic choriomeningitis virus infection of mice: analysis of the involvement of type 1 IFN.
  Montoya M, Edwards MJ, Reid DM, Borrow P. Montoya M, et al. J Immunol. 2005 Feb 15;174(4):1851-61. doi: 10.4049/jimmunol.174.4.1851. J Immunol. 2005. PMID: 15699111
• CD8 T cell dysfunction during chronic viral infection.
  Shin H, Wherry EJ. Shin H, et al. Curr Opin Immunol. 2007 Aug;19(4):408-15. doi: 10.1016/j.coi.2007.06.004. Epub 2007 Jul 25. Curr Opin Immunol. 2007. PMID: 17656078 Review.
• Type I interferon as a stimulus for cross-priming.
  Le Bon A, Tough DF. Le Bon A, et al. Cytokine Growth Factor Rev. 2008 Feb;19(1):33-40. doi: 10.1016/j.cytogfr.2007.10.007. Cytokine Growth Factor Rev. 2008. PMID: 18068417 Review.

Cited by

• Vaccinia virus infection induces dendritic cell maturation but inhibits antigen presentation by MHC class II.
  Yao Y, Li P, Singh P, Thiele AT, Wilkes DS, Renukaradhya GJ, Brutkiewicz RR, Travers JB, Luker GD, Hong SC, Blum JS, Chang CH. Yao Y, et al. Cell Immunol. 2007 Apr;246(2):92-102. doi: 10.1016/j.cellimm.2007.06.005. Epub 2007 Aug 2. Cell Immunol. 2007. PMID: 17678637 Free PMC article.
• A KALA-modified lipid nanoparticle containing CpG-free plasmid DNA as a potential DNA vaccine carrier for antigen presentation and as an immune-stimulative adjuvant.
  Miura N, Shaheen SM, Akita H, Nakamura T, Harashima H. Miura N, et al. Nucleic Acids Res. 2015 Feb 18;43(3):1317-31. doi: 10.1093/nar/gkv008. Epub 2015 Jan 20. Nucleic Acids Res. 2015. PMID: 25605799 Free PMC article.
• Plasmacytoid dendritic cells induce NK cell-dependent, tumor antigen-specific T cell cross-priming and tumor regression in mice.
  Liu C, Lou Y, Lizée G, Qin H, Liu S, Rabinovich B, Kim GJ, Wang YH, Ye Y, Sikora AG, Overwijk WW, Liu YJ, Wang G, Hwu P. Liu C, et al. J Clin Invest. 2008 Mar;118(3):1165-75. doi: 10.1172/JCI33583. J Clin Invest. 2008. PMID: 18259609 Free PMC article.
• Upregulated expression of cytotoxicity-related genes in IFN-γ knockout mice with Schistosoma japonicum infection.
  Du X, Wu J, Zhang M, Gao Y, Zhang D, Hou M, Ji M, Wu G. Du X, et al. J Biomed Biotechnol. 2011;2011:864945. doi: 10.1155/2011/864945. Epub 2011 Oct 1. J Biomed Biotechnol. 2011. PMID: 21976969 Free PMC article.
• A Sendai virus-derived RNA agonist of RIG-I as a virus vaccine adjuvant.
  Martínez-Gil L, Goff PH, Hai R, García-Sastre A, Shaw ML, Palese P. Martínez-Gil L, et al. J Virol. 2013 Feb;87(3):1290-300. doi: 10.1128/JVI.02338-12. Epub 2012 Nov 21. J Virol. 2013. PMID: 23175362 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Nature Publishing Group